The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Custom Recombinant Protein Production Services Market By 2030?
The custom recombinant protein production services market size has experienced rapid growth in recent years. It is anticipated to increase from $5.79 billion in 2025 to $6.47 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.8%. This historical expansion can be attributed to several factors: the increasing scope of academic and clinical research activities, the greater integration of recombinant proteins in drug discovery, the development of biopharmaceutical R&D pipelines, the widespread availability of advanced expression technologies, and the escalating demand for specialized research services.
The custom recombinant protein production services market size is anticipated to experience substantial growth in the upcoming years. It is projected to reach $10.21 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is driven by several factors, including the increasing development of biologics and biosimilars, rising investments in precision medicine, the expansion of contract research outsourcing, a growing demand for scalable protein production, and the wider adoption of advanced purification technologies. Prominent trends expected over the forecast period encompass an increasing demand for custom protein expression services, a rising use of mammalian expression systems, a growing focus on the production of high-purity proteins, the expansion of rapid turnaround research services, and an enhanced emphasis on quality control and validation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33077&type=smp
Which Growth Factors Are Strengthening The Custom Recombinant Protein Production Services Market Landscape?
An increasing emphasis on targeted and personalized therapies is anticipated to drive the expansion of the custom recombinant protein production services market moving forward. These medical treatments are designed to cater to individual patient characteristics, such as genetic profiles or specific disease markers, aiming to enhance treatment effectiveness and minimize side effects. The growth in targeted and personalized therapies is a result of advancements in precision medicine, which allows for treatments to be precisely tailored to an individual’s biology, thereby improving clinical outcomes and therapeutic efficiency. The custom recombinant protein production services support targeted and personalized therapies by supplying precisely engineered proteins vital for patient-specific drug development, biomarker identification, and advanced biologic treatments. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based hospital and health care organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Thus, the growing focus on targeted and personalized therapies is propelling the growth of the custom recombinant protein production services market.
What Segment Categories Are Evaluated In The Custom Recombinant Protein Production Services Market Study?
The custom recombinant protein production services market covered in this report is segmented –
1) By Product: Antibodies; Enzymes; Cytokines; Growth Factors; Recombinant Hormones
2) By Expression System: Mammalian; Bacteria; Insect; Yeast; Other Expression Systems
3) By Application: Drug Discovery; Biopharmaceutical Production; Diagnostics Development; Academic Research; Industrial Enzymes
4) By End User: Research Institutes; Biotechnology And Pharmaceutical Companies; Contract Research Organizations (CROs); Other End-Users
Subsegments:
1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Chimeric Antibodies; Humanized Antibodies; Single Chain Antibodies
2) By Enzymes: Proteases; Lipases; Amylases; Cellulases; Polymerases
3) By Cytokines: Interleukins; Interferons; Tumor Necrosis Factors; Colony Stimulating Factors; Chemokines
4) By Growth Factors: Epidermal Growth Factors; Fibroblast Growth Factors; Vascular Endothelial Growth Factors; Transforming Growth Factors; Platelet Derived Growth Factors
5) By Recombinant Hormones: Insulin; Erythropoietin; Growth Hormone; Thyroid Stimulating Hormone; Follicle Stimulating Hormone
What Trends Are Influencing The Custom Recombinant Protein Production Services Market Outlook?
Leading companies within the custom recombinant protein production services market are concentrating on introducing innovative microbial expression platforms, such as their unique E. coli expression systems, to boost protein production, enhance scalability, and reduce costs, thus accelerating the delivery of next-generation biologics. A proprietary E. coli expression system refers to a specialized, engineered E. coli bacterial strain designed for high-yield, stable, and efficient production of recombinant proteins and plasmid DNA, often tailored for specific biotechnological or pharmaceutical applications. For example, in March 2025, WuXi Biologics (Cayman) Inc., a China-based contract research, development, and manufacturing organization (CRDMO), launched its new EffiX Microbial Expression Platform. This platform delivers impressive titers exceeding 15 g/L for non-mAb recombinant proteins and more than 1 g/L for plasmid DNA. EffiX is positioned as a comprehensive solution for developing and manufacturing microbial-derived biologics, improving scalability, quality, and productivity across the biopharmaceutical industry.
Who Are The Businesses Driving Activity In The Custom Recombinant Protein Production Services Market?
Major companies operating in the custom recombinant protein production services market are Thermo Fisher Scientific Inc., Merck KGaA, Applied Biological Materials Inc., R&D Systems Inc., GenScript Biotech Corporation, Sino Biological Inc, Biointron Biological Inc., OriGene Technologies Inc., Crown Bioscience Inc., Premas Biotech, Eurofins Discovery, ATUM, BPS Bioscience Inc., Novoprotein Scientific Inc., Kempbio Inc., Proteos Inc., Trenzyme GmbH, LakePharma Inc., Icosagen AS, and ProteoGenix SAS.
Access The Complete Custom Recombinant Protein Production Services Market Report:
Which Region Leads The Custom Recombinant Protein Production Services Market By Size?
North America was the largest region in the custom recombinant protein production services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom recombinant protein production services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Custom Recombinant Protein Production Services Market Report for Deeper Competitive Insights
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model